Literature DB >> 20062068

The microRNA and p53 families join forces against cancer.

N A Barlev1, B S Sayan, E Candi, A L Okorokov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20062068     DOI： 10.1038/cdd.2009.73

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN： 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  22 in total

1.  Regulation of Endoribonuclease Activity of Alpha-Type Proteasome Subunits in Proerythroleukemia K562 Upon Hemin-Induced Differentiation.

Authors:  Alexey G Mittenberg; Tatyana N Moiseeva; Valeria O Kuzyk; Nickolai A Barlev
Journal:  Protein J       Date:  2016-02       Impact factor: 2.371

2.  MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer.

Authors:  Seong O Suh; Yi Chen; Mohd Saif Zaman; Hiroshi Hirata; Soichiro Yamamura; Varahram Shahryari; Jan Liu; Z Laura Tabatabai; Sanjay Kakar; Guoren Deng; Yuichiro Tanaka; Rajvir Dahiya
Journal:  Carcinogenesis       Date:  2011-02-23       Impact factor: 4.944

3.  Co-expression of RelA/p65 and ACTN4 induces apoptosis in non-small lung carcinoma cells.

Authors:  Ekaterina Lomert; Lidia Turoverova; Daria Kriger; Nikolai D Aksenov; Alina D Nikotina; Alexey Petukhov; Alexey G Mittenberg; Nikolai V Panyushev; Mikhail Khotin; Kirill Volkov; Nikolai A Barlev; Dmitri Tentler
Journal:  Cell Cycle       Date:  2018-01-22       Impact factor: 4.534

4.  MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma.

Authors:  Lei Jin; Wang Lai Hu; Chen Chen Jiang; Jia Xu Wang; Chuan Chun Han; Ping Chu; Lin Jie Zhang; Rick F Thorne; James Wilmott; Richard A Scolyer; Peter Hersey; Xu Dong Zhang; Mian Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-06       Impact factor: 11.205

5.  Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis.

Authors:  Olga Fedorova; Alexey Petukhov; Alexandra Daks; Oleg Shuvalov; Tatyana Leonova; Elena Vasileva; Nikolai Aksenov; Gerry Melino; Nikolai A Barlev
Journal:  Oncogene       Date:  2018-11-19       Impact factor: 9.867

6.  Combined treatment of human multiple myeloma cells with bortezomib and doxorubicin alters the interactome of 20S proteasomes.

Authors:  Alexey G Mittenberg; Valeria O Kuzyk; Sergey V Shabelnikov; Daria P Gorbach; Alla N Shatrova; Olga A Fedorova; Nickolai A Barlev
Journal:  Cell Cycle       Date:  2018-08-01       Impact factor: 4.534

7.  Novel isatin-derived molecules activate p53 via interference with Mdm2 to promote apoptosis.

Authors:  Olga Fedorova; Alexandra Daks; Varvara Petrova; Alexey Petukhov; Larissa Lezina; Oleg Shuvalov; Pavel Davidovich; Darya Kriger; Ekaterina Lomert; Dmitry Tentler; Victor Kartsev; Burhan Uyanik; Vyacheslav Tribulovich; Oleg Demidov; Gerry Melino; Nickolai A Barlev
Journal:  Cell Cycle       Date:  2018-09-05       Impact factor: 4.534

Review 8.  p63 the guardian of human reproduction.

Authors:  Ivano Amelio; Francesca Grespi; Margherita Annicchiarico-Petruzzelli; Gerry Melino
Journal:  Cell Cycle       Date:  2012-11-19       Impact factor: 4.534

9.  Identification of NCF2/p67phox as a novel p53 target gene.

Authors:  Dafne Italiano; Anna Maria Lena; Gerry Melino; Eleonora Candi
Journal:  Cell Cycle       Date:  2012-11-27       Impact factor: 4.534

Review 10.  NRF2 and p53: Januses in cancer?

Authors:  Barak Rotblat; Gerry Melino; Richard A Knight
Journal:  Oncotarget       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.